On the web today:
Ipsen (Euronext : FR0010259150; IPN) and Inspiration Biopharmaceuticals, Inc. (Inspiration) announced that the Committee for Orphan Medicinal Products of the European Medicines Agency has issued a positive opinion on the granting of orphan drug status for OBI-1 for the treatment of hemophilia. Final adoption of the opinion is expected from the European Commission later this year and subject to ...
And this:
Inspiration, an eco-friendly development in Bayport, is organizing a neighborhood cleanup and tree planting Saturday in honor of Earth Day and Arbor Day.
As well as:
Ipsen and Inspiration Biopharmaceuticals, Inc. announced today that the Committee for Orphan Medicinal Products of the European Medicines Agency has issued a positive opinion on the granting of orphan drug status for OBI-1 for the treatment of hemophilia. original. qopfvabo
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment